In SURPASS-2, which compared tirzepatide to semaglutide (a GLP-1 receptor agonist) in patients taking metformin, tirzepatide 5 mg, 10 mg, and 15 mg doses achieved mean HbA1c reductions of 2.01%, 2.24%, and 2.30% respectively from baseline, compared to 1.86% with semaglutide 1 mg
Ambros Labs supplies Tirzepatide to qualified researchers across Canada from our Canadian inventory
This means: Personalized Assessment and Eligibility: We conduct thorough virtual consultations and lab work review to determine if Wegovy weight loss or Zepbound weight loss is medically appropriate for you
Calculating injection volume from concentration The formula is straightforward: Injection volume (mL) = Desired dose (mg) / Concentration (mg/mL) For semaglutide at 5 mg/mL concentration, a 1.0 mg dose requires: 1.0 mg / 5 mg/mL = 0.20 mL = 20 units on an insulin syringe For tirzepatide at 20 mg/mL concentration, a 10 mg dose requires: 10 mg / 20 mg/mL = 0.50 mL = 50 units on an insulin syringe The semaglutide dosage calculator automates this math, and the general peptide calculator handles any peptide at any concentration
